Summary
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
According to APO Research, The global Celecoxib market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Celecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Celecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Celecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Celecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Celecoxib include Pfizer Inc, Teva, Mylan, Apotex, Lupin and Hengrui Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Celecoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Celecoxib, also provides the sales of main regions and countries. Of the upcoming market potential for Celecoxib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Celecoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Celecoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Celecoxib sales, projected growth trends, production technology, application and end-user industry.
Celecoxib segment by Company
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Celecoxib segment by Type
50mg
100mg
200mg
400mg
Celecoxib segment by Application
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Celecoxib segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Celecoxib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Celecoxib and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Celecoxib.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Celecoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celecoxib sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Celecoxib Market by Type
1.2.1 Global Celecoxib Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib Market by Application
1.3.1 Global Celecoxib Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Celecoxib Market Dynamics
2.1 Celecoxib Industry Trends
2.2 Celecoxib Industry Drivers
2.3 Celecoxib Industry Opportunities and Challenges
2.4 Celecoxib Industry Restraints
3 Global Market Growth Prospects
3.1 Global Celecoxib Revenue Estimates and Forecasts (2019-2030)
3.2 Global Celecoxib Revenue by Region
3.2.1 Global Celecoxib Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Celecoxib Revenue by Region (2019-2024)
3.2.3 Global Celecoxib Revenue by Region (2025-2030)
3.2.4 Global Celecoxib Revenue Market Share by Region (2019-2030)
3.3 Global Celecoxib Sales Estimates and Forecasts 2019-2030
3.4 Global Celecoxib Sales by Region
3.4.1 Global Celecoxib Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Celecoxib Sales by Region (2019-2024)
3.4.3 Global Celecoxib Sales by Region (2025-2030)
3.4.4 Global Celecoxib Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Celecoxib Revenue by Manufacturers
4.1.1 Global Celecoxib Revenue by Manufacturers (2019-2024)
4.1.2 Global Celecoxib Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Celecoxib Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Celecoxib Sales by Manufacturers
4.2.1 Global Celecoxib Sales by Manufacturers (2019-2024)
4.2.2 Global Celecoxib Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Celecoxib Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Celecoxib Sales Price by Manufacturers (2019-2024)
4.4 Global Celecoxib Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Celecoxib Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Celecoxib Manufacturers, Product Type & Application
4.7 Global Celecoxib Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Celecoxib Market CR5 and HHI
4.8.2 2023 Celecoxib Tier 1, Tier 2, and Tier 3
5 Celecoxib Market by Type
5.1 Global Celecoxib Revenue by Type
5.1.1 Global Celecoxib Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Celecoxib Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Celecoxib Revenue Market Share by Type (2019-2030)
5.2 Global Celecoxib Sales by Type
5.2.1 Global Celecoxib Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Celecoxib Sales by Type (2019-2030) & (K Units)
5.2.3 Global Celecoxib Sales Market Share by Type (2019-2030)
5.3 Global Celecoxib Price by Type
6 Celecoxib Market by Application
6.1 Global Celecoxib Revenue by Application
6.1.1 Global Celecoxib Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Celecoxib Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Celecoxib Revenue Market Share by Application (2019-2030)
6.2 Global Celecoxib Sales by Application
6.2.1 Global Celecoxib Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Celecoxib Sales by Application (2019-2030) & (K Units)
6.2.3 Global Celecoxib Sales Market Share by Application (2019-2030)
6.3 Global Celecoxib Price by Application
7 Company Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Comapny Information
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Pfizer Inc Celecoxib Product Portfolio
7.1.5 Pfizer Inc Recent Developments
7.2 Teva
7.2.1 Teva Comapny Information
7.2.2 Teva Business Overview
7.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Teva Celecoxib Product Portfolio
7.2.5 Teva Recent Developments
7.3 Mylan
7.3.1 Mylan Comapny Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mylan Celecoxib Product Portfolio
7.3.5 Mylan Recent Developments
7.4 Apotex
7.4.1 Apotex Comapny Information
7.4.2 Apotex Business Overview
7.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Apotex Celecoxib Product Portfolio
7.4.5 Apotex Recent Developments
7.5 Lupin
7.5.1 Lupin Comapny Information
7.5.2 Lupin Business Overview
7.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Lupin Celecoxib Product Portfolio
7.5.5 Lupin Recent Developments
7.6 Hengrui Medicine
7.6.1 Hengrui Medicine Comapny Information
7.6.2 Hengrui Medicine Business Overview
7.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Hengrui Medicine Celecoxib Product Portfolio
7.6.5 Hengrui Medicine Recent Developments
8 North America
8.1 North America Celecoxib Market Size by Type
8.1.1 North America Celecoxib Revenue by Type (2019-2030)
8.1.2 North America Celecoxib Sales by Type (2019-2030)
8.1.3 North America Celecoxib Price by Type (2019-2030)
8.2 North America Celecoxib Market Size by Application
8.2.1 North America Celecoxib Revenue by Application (2019-2030)
8.2.2 North America Celecoxib Sales by Application (2019-2030)
8.2.3 North America Celecoxib Price by Application (2019-2030)
8.3 North America Celecoxib Market Size by Country
8.3.1 North America Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Celecoxib Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Celecoxib Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Celecoxib Market Size by Type
9.1.1 Europe Celecoxib Revenue by Type (2019-2030)
9.1.2 Europe Celecoxib Sales by Type (2019-2030)
9.1.3 Europe Celecoxib Price by Type (2019-2030)
9.2 Europe Celecoxib Market Size by Application
9.2.1 Europe Celecoxib Revenue by Application (2019-2030)
9.2.2 Europe Celecoxib Sales by Application (2019-2030)
9.2.3 Europe Celecoxib Price by Application (2019-2030)
9.3 Europe Celecoxib Market Size by Country
9.3.1 Europe Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Celecoxib Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Celecoxib Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Celecoxib Market Size by Type
10.1.1 China Celecoxib Revenue by Type (2019-2030)
10.1.2 China Celecoxib Sales by Type (2019-2030)
10.1.3 China Celecoxib Price by Type (2019-2030)
10.2 China Celecoxib Market Size by Application
10.2.1 China Celecoxib Revenue by Application (2019-2030)
10.2.2 China Celecoxib Sales by Application (2019-2030)
10.2.3 China Celecoxib Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Celecoxib Market Size by Type
11.1.1 Asia Celecoxib Revenue by Type (2019-2030)
11.1.2 Asia Celecoxib Sales by Type (2019-2030)
11.1.3 Asia Celecoxib Price by Type (2019-2030)
11.2 Asia Celecoxib Market Size by Application
11.2.1 Asia Celecoxib Revenue by Application (2019-2030)
11.2.2 Asia Celecoxib Sales by Application (2019-2030)
11.2.3 Asia Celecoxib Price by Application (2019-2030)
11.3 Asia Celecoxib Market Size by Country
11.3.1 Asia Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Celecoxib Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Celecoxib Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Celecoxib Market Size by Type
12.1.1 MEALA Celecoxib Revenue by Type (2019-2030)
12.1.2 MEALA Celecoxib Sales by Type (2019-2030)
12.1.3 MEALA Celecoxib Price by Type (2019-2030)
12.2 MEALA Celecoxib Market Size by Application
12.2.1 MEALA Celecoxib Revenue by Application (2019-2030)
12.2.2 MEALA Celecoxib Sales by Application (2019-2030)
12.2.3 MEALA Celecoxib Price by Application (2019-2030)
12.3 MEALA Celecoxib Market Size by Country
12.3.1 MEALA Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Celecoxib Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Celecoxib Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Celecoxib Value Chain Analysis
13.1.1 Celecoxib Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Celecoxib Production Mode & Process
13.2 Celecoxib Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Celecoxib Distributors
13.2.3 Celecoxib Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Celecoxib Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. 50mg Major Manufacturers
Table 3. 100mg Major Manufacturers
Table 4. 200mg Major Manufacturers
Table 5. 400mg Major Manufacturers
Table 6. Global Celecoxib Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Rheumatoid arthritis Major Manufacturers
Table 8. osteoarthritis Major Manufacturers
Table 9. Acute pain Major Manufacturers
Table 10. Musculoskeletal pain Major Manufacturers
Table 11. Other diseases Major Manufacturers
Table 12. Celecoxib Industry Trends
Table 13. Celecoxib Industry Drivers
Table 14. Celecoxib Industry Opportunities and Challenges
Table 15. Celecoxib Industry Restraints
Table 16. Global Celecoxib Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Celecoxib Revenue by Region (2019-2024) & (US$ Million)
Table 18. Global Celecoxib Revenue by Region (2025-2030) & (US$ Million)
Table 19. Global Celecoxib Revenue Market Share by Region (2019-2024)
Table 20. Global Celecoxib Revenue Market Share by Region (2025-2030)
Table 21. Global Celecoxib Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Celecoxib Sales by Region (2019-2024) & (K Units)
Table 23. Global Celecoxib Sales by Region (2025-2030) & (K Units)
Table 24. Global Celecoxib Sales Market Share by Region (2019-2024)
Table 25. Global Celecoxib Sales Market Share by Region (2025-2030)
Table 26. Global Celecoxib Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 27. Global Celecoxib Revenue Market Share by Manufacturers (2019-2024)
Table 28. Global Celecoxib Sales by Manufacturers (US$ Million) & (2019-2024)
Table 29. Global Celecoxib Sales Market Share by Manufacturers (2019-2024)
Table 30. Global Celecoxib Sales Price (US$/Unit) of Manufacturers (2019-2024)
Table 31. Global Celecoxib Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 32. Global Celecoxib Key Manufacturers Manufacturing Sites & Headquarters
Table 33. Global Celecoxib Manufacturers, Product Type & Application
Table 34. Global Celecoxib Manufacturers Commercialization Time
Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Celecoxib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 37. Global Celecoxib Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Celecoxib Revenue by Type (2019-2024) & (US$ Million)
Table 39. Global Celecoxib Revenue by Type (2025-2030) & (US$ Million)
Table 40. Global Celecoxib Revenue Market Share by Type (2019-2024)
Table 41. Global Celecoxib Revenue Market Share by Type (2025-2030)
Table 42. Global Celecoxib Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 43. Global Celecoxib Sales by Type (2019-2024) & (K Units)
Table 44. Global Celecoxib Sales by Type (2025-2030) & (K Units)
Table 45. Global Celecoxib Sales Market Share by Type (2019-2024)
Table 46. Global Celecoxib Sales Market Share by Type (2025-2030)
Table 47. Global Celecoxib Price by Type (2019-2024) & (US$/Unit)
Table 48. Global Celecoxib Price by Type (2025-2030) & (US$/Unit)
Table 49. Global Celecoxib Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 50. Global Celecoxib Revenue by Application (2019-2024) & (US$ Million)
Table 51. Global Celecoxib Revenue by Application (2025-2030) & (US$ Million)
Table 52. Global Celecoxib Revenue Market Share by Application (2019-2024)
Table 53. Global Celecoxib Revenue Market Share by Application (2025-2030)
Table 54. Global Celecoxib Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 55. Global Celecoxib Sales by Application (2019-2024) & (K Units)
Table 56. Global Celecoxib Sales by Application (2025-2030) & (K Units)
Table 57. Global Celecoxib Sales Market Share by Application (2019-2024)
Table 58. Global Celecoxib Sales Market Share by Application (2025-2030)
Table 59. Global Celecoxib Price by Application (2019-2024) & (US$/Unit)
Table 60. Global Celecoxib Price by Application (2025-2030) & (US$/Unit)
Table 61. Pfizer Inc Company Information
Table 62. Pfizer Inc Business Overview
Table 63. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 64. Pfizer Inc Celecoxib Product Portfolio
Table 65. Pfizer Inc Recent Development
Table 66. Teva Company Information
Table 67. Teva Business Overview
Table 68. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 69. Teva Celecoxib Product Portfolio
Table 70. Teva Recent Development
Table 71. Mylan Company Information
Table 72. Mylan Business Overview
Table 73. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 74. Mylan Celecoxib Product Portfolio
Table 75. Mylan Recent Development
Table 76. Apotex Company Information
Table 77. Apotex Business Overview
Table 78. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Apotex Celecoxib Product Portfolio
Table 80. Apotex Recent Development
Table 81. Lupin Company Information
Table 82. Lupin Business Overview
Table 83. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Lupin Celecoxib Product Portfolio
Table 85. Lupin Recent Development
Table 86. Hengrui Medicine Company Information
Table 87. Hengrui Medicine Business Overview
Table 88. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Hengrui Medicine Celecoxib Product Portfolio
Table 90. Hengrui Medicine Recent Development
Table 91. North America Celecoxib Revenue by Type (2019-2024) & (US$ Million)
Table 92. North America Celecoxib Revenue by Type (2025-2030) & (US$ Million)
Table 93. North America Celecoxib Sales by Type (2019-2024) & (K Units)
Table 94. North America Celecoxib Sales by Type (2025-2030) & (K Units)
Table 95. North America Celecoxib Sales Price by Type (2019-2024) & (US$/Unit)
Table 96. North America Celecoxib Sales Price by Type (2025-2030) & (US$/Unit)
Table 97. North America Celecoxib Revenue by Application (2019-2024) & (US$ Million)
Table 98. North America Celecoxib Revenue by Application (2025-2030) & (US$ Million)
Table 99. North America Celecoxib Sales by Application (2019-2024) & (K Units)
Table 100. North America Celecoxib Sales by Application (2025-2030) & (K Units)
Table 101. North America Celecoxib Sales Price by Application (2019-2024) & (US$/Unit)
Table 102. North America Celecoxib Sales Price by Application (2025-2030) & (US$/Unit)
Table 103. North America Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 104. North America Celecoxib Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 105. North America Celecoxib Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 106. North America Celecoxib Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 107. North America Celecoxib Sales by Country (2019-2024) & (K Units)
Table 108. North America Celecoxib Sales by Country (2025-2030) & (K Units)
Table 109. North America Celecoxib Sales Price by Country (2019-2024) & (US$/Unit)
Table 110. North America Celecoxib Sales Price by Country (2025-2030) & (US$/Unit)
Table 111. US Celecoxib Revenue (2019-2030) & (US$ Million)
Table 112. Canada Celecoxib Revenue (2019-2030) & (US$ Million)
Table 113. Europe Celecoxib Revenue by Type (2019-2024) & (US$ Million)
Table 114. Europe Celecoxib Revenue by Type (2025-2030) & (US$ Million)
Table 115. Europe Celecoxib Sales by Type (2019-2024) & (K Units)
Table 116. Europe Celecoxib Sales by Type (2025-2030) & (K Units)
Table 117. Europe Celecoxib Sales Price by Type (2019-2024) & (US$/Unit)
Table 118. Europe Celecoxib Sales Price by Type (2025-2030) & (US$/Unit)
Table 119. Europe Celecoxib Revenue by Application (2019-2024) & (US$ Million)
Table 120. Europe Celecoxib Revenue by Application (2025-2030) & (US$ Million)
Table 121. Europe Celecoxib Sales by Application (2019-2024) & (K Units)
Table 122. Europe Celecoxib Sales by Application (2025-2030) & (K Units)
Table 123. Europe Celecoxib Sales Price by Application (2019-2024) & (US$/Unit)
Table 124. Europe Celecoxib Sales Price by Application (2025-2030) & (US$/Unit)
Table 125. Europe Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 126. Europe Celecoxib Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 127. Europe Celecoxib Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 128. Europe Celecoxib Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 129. Europe Celecoxib Sales by Country (2019-2024) & (K Units)
Table 130. Europe Celecoxib Sales by Country (2025-2030) & (K Units)
Table 131. Europe Celecoxib Sales Price by Country (2019-2024) & (US$/Unit)
Table 132. Europe Celecoxib Sales Price by Country (2025-2030) & (US$/Unit)
Table 133. Germany Celecoxib Revenue (2019-2030) & (US$ Million)
Table 134. France Celecoxib Revenue (2019-2030) & (US$ Million)
Table 135. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 136. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 137. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 138. China Celecoxib Revenue by Type (2019-2024) & (US$ Million)
Table 139. China Celecoxib Revenue by Type (2025-2030) & (US$ Million)
Table 140. China Celecoxib Sales by Type (2019-2024) & (K Units)
Table 141. China Celecoxib Sales by Type (2025-2030) & (K Units)
Table 142. China Celecoxib Sales Price by Type (2019-2024) & (US$/Unit)
Table 143. China Celecoxib Sales Price by Type (2025-2030) & (US$/Unit)
Table 144. China Celecoxib Revenue by Application (2019-2024) & (US$ Million)
Table 145. China Celecoxib Revenue by Application (2025-2030) & (US$ Million)
Table 146. China Celecoxib Sales by Application (2019-2024) & (K Units)
Table 147. China Celecoxib Sales by Application (2025-2030) & (K Units)
Table 148. China Celecoxib Sales Price by Application (2019-2024) & (US$/Unit)
Table 149. China Celecoxib Sales Price by Application (2025-2030) & (US$/Unit)
Table 150. Asia Celecoxib Revenue by Type (2019-2024) & (US$ Million)
Table 151. Asia Celecoxib Revenue by Type (2025-2030) & (US$ Million)
Table 152. Asia Celecoxib Sales by Type (2019-2024) & (K Units)
Table 153. Asia Celecoxib Sales by Type (2025-2030) & (K Units)
Table 154. Asia Celecoxib Sales Price by Type (2019-2024) & (US$/Unit)
Table 155. Asia Celecoxib Sales Price by Type (2025-2030) & (US$/Unit)
Table 156. Asia Celecoxib Revenue by Application (2019-2024) & (US$ Million)
Table 157. Asia Celecoxib Revenue by Application (2025-2030) & (US$ Million)
Table 158. Asia Celecoxib Sales by Application (2019-2024) & (K Units)
Table 159. Asia Celecoxib Sales by Application (2025-2030) & (K Units)
Table 160. Asia Celecoxib Sales Price by Application (2019-2024) & (US$/Unit)
Table 161. Asia Celecoxib Sales Price by Application (2025-2030) & (US$/Unit)
Table 162. Asia Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 163. Asia Celecoxib Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 164. Asia Celecoxib Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 165. Asia Celecoxib Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 166. Asia Celecoxib Sales by Country (2019-2024) & (K Units)
Table 167. Asia Celecoxib Sales by Country (2025-2030) & (K Units)
Table 168. Asia Celecoxib Sales Price by Country (2019-2024) & (US$/Unit)
Table 169. Asia Celecoxib Sales Price by Country (2025-2030) & (US$/Unit)
Table 170. Japan Celecoxib Revenue (2019-2030) & (US$ Million)
Table 171. South Korea Celecoxib Revenue (2019-2030) & (US$ Million)
Table 172. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 173. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 174. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 175. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 176. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 177. Celecoxib Revenue (2019-2030) & (US$ Million)
Table 178. MEALA Celecoxib Revenue by Type (2019-2024) & (US$ Million)
Table 179. MEALA Celecoxib Revenue by Type (2025-2030) & (US$ Million)
Table 180. MEALA Celecoxib Sales by Type (2019-2024) & (K Units)
Table 181. MEALA Celecoxib Sales by Type (2025-2030) & (K Units)
Table 182. MEALA Celecoxib Sales Price by Type (2019-2024) & (US$/Unit)
Table 183. MEALA Celecoxib Sales Price by Type (2025-2030) & (US$/Unit)
Table 184. MEALA Celecoxib Revenue by Application (2019-2024) & (US$ Million)
Table 185. MEALA Celecoxib Revenue by Application (2025-2030) & (US$ Million)
Table 186. MEALA Celecoxib Sales by Application (2019-2024) & (K Units)
Table 187. MEALA Celecoxib Sales by Application (2025-2030) & (K Units)
Table 188. MEALA Celecoxib Sales Price by Application (2019-2024) & (US$/Unit)
Table 189. MEALA Celecoxib Sales Price by Application (2025-2030) & (US$/Unit)
Table 190. MEALA Celecoxib Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 191. MEALA Celecoxib Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 192. MEALA Celecoxib Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 193. MEALA Celecoxib Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 194. MEALA Celecoxib Sales by Country (2019-2024) & (K Units)
Table 195. MEALA Celecoxib Sales by Country (2025-2030) & (K Units)
Table 196. MEALA Celecoxib Sales Price by Country (2019-2024) & (US$/Unit)
Table 197. MEALA Celecoxib Sales Price by Country (2025-2030) & (US$/Unit)
Table 198. Mexico Celecoxib Revenue (2019-2030) & (US$ Million)
Table 199. Brazil Celecoxib Revenue (2019-2030) & (US$ Million)
Table 200. Israel Celecoxib Revenue (2019-2030) & (US$ Million)
Table 201. Argentina Celecoxib Revenue (2019-2030) & (US$ Million)
Table 202. Colombia Celecoxib Revenue (2019-2030) & (US$ Million)
Table 203. Turkey Celecoxib Revenue (2019-2030) & (US$ Million)
Table 204. Saudi Arabia Celecoxib Revenue (2019-2030) & (US$ Million)
Table 205. UAE Celecoxib Revenue (2019-2030) & (US$ Million)
Table 206. Key Raw Materials
Table 207. Raw Materials Key Suppliers
Table 208. Celecoxib Distributors List
Table 209. Celecoxib Customers List
Table 210. Research Programs/Design for This Report
Table 211. Authors List of This Report
Table 212. Secondary Sources
Table 213. Primary Sources
List of Figures
Figure 1. Celecoxib Product Picture
Figure 2. Global Celecoxib Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Celecoxib Market Size Share 2019 VS 2023 VS 2030
Figure 4. 50mg Picture
Figure 5. 100mg Picture
Figure 6. 200mg Picture
Figure 7. 400mg Picture
Figure 8. Global Celecoxib Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Celecoxib Market Size Share 2019 VS 2023 VS 2030
Figure 10. Rheumatoid arthritis Picture
Figure 11. osteoarthritis Picture
Figure 12. Acute pain Picture
Figure 13. Musculoskeletal pain Picture
Figure 14. Other diseases Picture
Figure 15. Global Celecoxib Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Celecoxib Revenue (2019-2030) & (US$ Million)
Figure 17. Global Celecoxib Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 18. Global Celecoxib Revenue Market Share by Region: 2023 Versus 2030
Figure 19. Global Celecoxib Revenue Market Share by Region (2019-2030)
Figure 20. Global Celecoxib Sales (2019-2030) & (K Units)
Figure 21. Global Celecoxib Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 22. Global Celecoxib Sales Market Share by Region (2019-2030)
Figure 23. US & Canada Celecoxib Sales YoY (2019-2030) & (K Units)
Figure 24. Europe Celecoxib Sales YoY (2019-2030) & (K Units)
Figure 25. China Celecoxib Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (Excluding China) Celecoxib Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America (Excluding China) Celecoxib Sales YoY (2019-2030) & (K Units)
Figure 28. Global Celecoxib Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 29. Global Celecoxib Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Celecoxib Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 32. Global Celecoxib Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 33. Global Celecoxib Revenue Market Share by Type (2019-2030)
Figure 34. Global Celecoxib Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 35. Global Celecoxib Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 36. Global Celecoxib Sales Market Share by Type (2019-2030)
Figure 37. Global Celecoxib Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 38. Global Celecoxib Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 39. Global Celecoxib Revenue Market Share by Application (2019-2030)
Figure 40. Global Celecoxib Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 41. Global Celecoxib Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 42. Global Celecoxib Sales Market Share by Application (2019-2030)
Figure 43. North America Celecoxib Revenue Share by Type (2019-2030)
Figure 44. North America Celecoxib Sales Share by Type (2019-2030)
Figure 45. North America Celecoxib Revenue Share by Application (2019-2030)
Figure 46. North America Celecoxib Sales Share by Application (2019-2030)
Figure 47. North America Celecoxib Revenue Share by Country (2019-2030)
Figure 48. North America Celecoxib Sales Share by Country (2019-2030)
Figure 49. Europe Celecoxib Revenue Share by Type (2019-2030)
Figure 50. Europe Celecoxib Sales Share by Type (2019-2030)
Figure 51. Europe Celecoxib Revenue Share by Application (2019-2030)
Figure 52. Europe Celecoxib Sales Share by Application (2019-2030)
Figure 53. Europe Celecoxib Revenue Share by Country (2019-2030)
Figure 54. Europe Celecoxib Sales Share by Country (2019-2030)
Figure 55. China Celecoxib Revenue Share by Type (2019-2030)
Figure 56. China Celecoxib Sales Share by Type (2019-2030)
Figure 57. China Celecoxib Revenue Share by Application (2019-2030)
Figure 58. China Celecoxib Sales Share by Application (2019-2030)
Figure 59. Asia Celecoxib Revenue Share by Type (2019-2030)
Figure 60. Asia Celecoxib Sales Share by Type (2019-2030)
Figure 61. Asia Celecoxib Revenue Share by Application (2019-2030)
Figure 62. Asia Celecoxib Sales Share by Application (2019-2030)
Figure 63. Asia Celecoxib Revenue Share by Country (2019-2030)
Figure 64. Asia Celecoxib Sales Share by Country (2019-2030)
Figure 65. MEALA Celecoxib Revenue Share by Type (2019-2030)
Figure 66. MEALA Celecoxib Sales Share by Type (2019-2030)
Figure 67. MEALA Celecoxib Revenue Share by Application (2019-2030)
Figure 68. MEALA Celecoxib Sales Share by Application (2019-2030)
Figure 69. MEALA Celecoxib Revenue Share by Country (2019-2030)
Figure 70. MEALA Celecoxib Sales Share by Country (2019-2030)
Figure 71. Celecoxib Value Chain
Figure 72. Manufacturing Cost Structure
Figure 73. Celecoxib Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
